Dapagliflozin

Amber-G

Brand Name(s):Forxiga

Indication:Chronic heart failure

Rationale:

Considered:Mar-21

Review Date:Mar-26

Comments:
NICE TA 679 February 21:
Dapagliflozin is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction only if used as an add-on to optimised standard care outlined in guidance TA679. Dapagliflozin should only be started on advice from a heart failure specialist.